Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$24M Sell
438,277
-72,332
-14% -$4.1M 0.25% 122
2014
Q4
$27.7M Buy
510,609
+185,358
+57% +$10.3M 0.29% 111
2014
Q3
$18.4M Sell
325,251
-16,817
-5% -$944K 0.26% 114
2014
Q2
$18.9M Sell
342,068
-20,954
-6% -$1.14M 0.26% 107
2014
Q1
$19.7M Sell
363,022
-85,841
-19% -$4.44M 0.29% 104
2013
Q4
$21.4M Sell
448,863
-20,574
-4% -$940K 0.37% 60
2013
Q3
$21.3M Buy
469,437
+4,104
+0.9% +$187K 0.4% 57
2013
Q2
$20.6M Buy
+465,333
New +$20.8M 0.41% 54

Other funds holding MRK

Baird's MRK Position: Q1 2015 in Review

Baird reduced its Merck (MRK) stake by 14% in Q1 2015, selling an estimated $4.1M and leaving 438,277 shares worth $24M. The position accounts for 0.25% of the portfolio, ranked #122.

Baird first reported a position in MRK in Q2 2013 and has held it in 8 quarters since. The position peaked at $27.7M in Q4 2014. 1,711 funds tracked by Wall St. Rank hold MRK as of Q1 2015.

  • Baird held 438,277 shares of Merck worth $24M as of Q1 2015.
  • Baird sold 72,332 Merck shares in Q1 2015, an estimated $4.1M.
  • Merck made up 0.25% of Baird's portfolio in Q1 2015, its #122 holding.
  • Baird first reported a position in Merck in Q2 2013 and has held it in 8 quarters since.
  • Baird's Merck position peaked at $27.7M in Q4 2014.
  • 1,711 funds tracked by Wall St. Rank held Merck as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.